Fresenius SE & Co KGaA (FSNUY)
8.78
+0.16
(+1.86%)
USD |
OTCM |
Nov 15, 16:00
Fresenius Debt to Equity Ratio: 0.6278 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.6278 |
| June 30, 2024 | 0.6299 |
| March 31, 2024 | 0.6433 |
| December 31, 2023 | 0.728 |
| September 30, 2023 | 0.6502 |
| June 30, 2023 | 1.084 |
| March 31, 2023 | 1.038 |
| December 31, 2022 | 1.037 |
| September 30, 2022 | 1.009 |
| June 30, 2022 | 1.041 |
| March 31, 2022 | 1.038 |
| December 31, 2021 | 1.082 |
| September 30, 2021 | 1.136 |
| June 30, 2021 | 1.184 |
| March 31, 2021 | 1.131 |
| December 31, 2020 | 1.164 |
| September 30, 2020 | 1.223 |
| June 30, 2020 | 1.200 |
| March 31, 2020 | 1.282 |
| December 31, 2019 | 1.241 |
| September 30, 2019 | 1.242 |
| June 30, 2019 | 1.303 |
| March 31, 2019 | 1.258 |
| December 31, 2018 | 1.232 |
| September 30, 2018 | 1.280 |
| Date | Value |
|---|---|
| June 30, 2018 | 1.320 |
| March 31, 2018 | 1.383 |
| December 31, 2017 | 1.394 |
| September 30, 2017 | 1.475 |
| June 30, 2017 | 1.523 |
| March 31, 2017 | 1.494 |
| December 31, 2016 | 1.167 |
| September 30, 2016 | 1.237 |
| June 30, 2016 | 1.323 |
| March 31, 2016 | 1.318 |
| December 31, 2015 | 1.351 |
| September 30, 2015 | 1.467 |
| June 30, 2015 | 1.541 |
| March 31, 2015 | 1.550 |
| December 31, 2014 | 1.644 |
| September 30, 2014 | 1.626 |
| June 30, 2014 | 1.707 |
| March 31, 2014 | 1.632 |
| December 31, 2013 | 1.551 |
| September 30, 2013 | 1.412 |
| June 30, 2013 | 1.434 |
| March 31, 2013 | 1.388 |
| December 31, 2012 | 1.432 |
| September 30, 2012 | 1.509 |
| June 30, 2012 | 1.645 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.6278
Minimum
Sep 2024
1.282
Maximum
Mar 2020
1.008
Average
1.062
Median
Debt to Equity Ratio Benchmarks
| Affimed NV | 0.3286 |
| InflaRx NV | 0.00 |
| BioNTech SE | 0.0127 |
| Immatics NV | 0.00 |
| CureVac NV | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 47.32B |
| Total Liabilities (Quarterly) | 25.65B |
| Shareholders Equity (Quarterly) | 21.03B |
| Current Ratio | 1.356 |
| Net Debt Paydown Yield | 9.70% |